Beryl Drugs Limited announced earnings results for the fourth quarter ended March 31, 2019. For the fourth quarter, the company announced total revenue was INR 24.094 million compared to INR 41.825 million a year ago. Net income was INR 1.035 million compared to INR 2.512 million a year ago. Basic earnings per share from continuing operations was INR 0.2 compared to INR 0.5 a year ago. For the full year, total revenue was INR 132.036 million compared to INR 159.435 million a year ago. Net income was INR 5.907 million compared to INR 9.929 million a year ago. Basic earnings per share from continuing operations was INR 1.16 compared to INR 1.96 a year ago.